Hopson Development Holdings Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Kut Yung Chu
Chief Executive Officer (CEO)
HK$5.2m
Compensación total
Porcentaje del salario del CEO | 100.0% |
Permanencia del CEO | 13yrs |
Participación del CEO | 0.2% |
Permanencia media de la dirección | less than a year |
Promedio de permanencia en la Junta Directiva | 9.7yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Jun 30 2024 | n/a | n/a | HK$92m |
Mar 31 2024 | n/a | n/a | HK$2b |
Dec 31 2023 | HK$5m | HK$5m | HK$3b |
Sep 30 2023 | n/a | n/a | HK$5b |
Jun 30 2023 | n/a | n/a | HK$6b |
Mar 31 2023 | n/a | n/a | HK$8b |
Dec 31 2022 | HK$5m | HK$5m | HK$9b |
Sep 30 2022 | n/a | n/a | HK$10b |
Jun 30 2022 | n/a | n/a | HK$11b |
Mar 31 2022 | n/a | n/a | HK$10b |
Dec 31 2021 | HK$3m | HK$3m | HK$10b |
Sep 30 2021 | n/a | n/a | HK$12b |
Jun 30 2021 | n/a | n/a | HK$14b |
Mar 31 2021 | n/a | n/a | HK$14b |
Dec 31 2020 | HK$2m | HK$2m | HK$14b |
Sep 30 2020 | n/a | n/a | HK$13b |
Jun 30 2020 | n/a | n/a | HK$12b |
Mar 31 2020 | n/a | n/a | HK$11b |
Dec 31 2019 | HK$2m | n/a | HK$9b |
Sep 30 2019 | n/a | n/a | HK$8b |
Jun 30 2019 | n/a | n/a | HK$6b |
Mar 31 2019 | n/a | n/a | HK$6b |
Dec 31 2018 | HK$2m | n/a | HK$6b |
Sep 30 2018 | n/a | n/a | HK$6b |
Jun 30 2018 | n/a | n/a | HK$7b |
Mar 31 2018 | n/a | n/a | HK$6b |
Dec 31 2017 | HK$2m | n/a | HK$6b |
Compensación vs. Mercado: La compensación total de Kut Yung($USD664.98K) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD481.65K).
Compensación vs. Ingresos: La compensación de Kut Yung ha sido consistente con los resultados de la empresa en el último año.
CEO
Kut Yung Chu (36 yo)
13yrs
Permanencia
HK$5,174,000
Compensación
Ms. Kut Yung Chu has been Chief Executive Officer of Hopson Development Holdings Limited and served as its Executive Vice President since March 2012. Ms. Chu has solid knowledge in finance principles and a...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Chairman of the Board & CEO | no data | HK$5.17m | 0.23% HK$ 27.0m | |
President & Executive Director | less than a year | HK$2.30m | sin datos | |
Executive Director | no data | HK$240.00k | 1.6% HK$ 185.5m | |
VP, Chairman of Business Investment Department & Executive Director | no data | HK$1.58m | sin datos | |
CFO & Executive Director | less than a year | sin datos | sin datos | |
Assistant President and GM of Investment & Financial Management Centre | no data | sin datos | sin datos | |
Investor Relations Officer | no data | sin datos | sin datos | |
Chief Human Resources Officer & Assistant President | no data | sin datos | sin datos | |
Assistant President of the Group & Executive VP of Business Management | no data | sin datos | sin datos | |
Company Secretary | 2.3yrs | sin datos | sin datos |
0.8yrs
Permanencia media
46yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 754 no se considera experimentado ( 0.8 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Chairman of the Board & CEO | 13yrs | HK$5.17m | 0.23% HK$ 27.0m | |
President & Executive Director | 4yrs | HK$2.30m | sin datos | |
Executive Director | 27.8yrs | HK$240.00k | 1.6% HK$ 185.5m | |
VP, Chairman of Business Investment Department & Executive Director | 10yrs | HK$1.58m | sin datos | |
CFO & Executive Director | less than a year | sin datos | sin datos | |
Independent Non-Executive Director | 9.3yrs | HK$370.00k | sin datos | |
Independent Non-Executive Director | 14.3yrs | HK$370.00k | sin datos | |
Independent Non-Executive Director | 3.5yrs | HK$370.00k | sin datos |
9.7yrs
Permanencia media
56yo
Promedio de edad
Junta con experiencia: La junta directiva de 754 se considera experimentada (9.7 años de antigüedad promedio).